AUG 21, 2016 8:30 AM PDT

Could an Eye Scan Reveal Early Parkinson's Disease?

WRITTEN BY: Xuan Pham
University College London scientists reported a potential new method of detecting Parkinson’s disease with a retina scan. The non-invasive eye test could be the first to screen patients for Parkinson’s disease years before symptoms like tremors and muscle stiffness develop.
 
Retina exam may detect Parkinson's before symptoms appear | Image: pixabay.com

"This is potentially a revolutionary breakthrough in the early diagnosis and treatment of one of the world's most debilitating diseases," said Francesca Cordeiro, Professor of Glaucoma & Retinal Neurodegeneration Studies at UCL, who led the research.
 
Parkinson’s disease is a neurological disease characterized by progressive neurodegeneration, causing severe impairments in movement. This disease affects nearly 10 million people worldwide. Most often, the disease is associated with involuntary, uncontrolled tremors; however, patients can also suffer from muscle stiffness and the difficulty moving or speaking.
 
Because the disease is progressive, symptoms worsen over time. There are no cures, but medications can improve some of the symptoms, especially if the disease is diagnosed at early stages.
 
UCL scientists studying Parkinson’s in a rat model found that the animals’ retina developed changes before the characteristic limb tremor and stiffness occurred. In particular, the scientists noted the rats’ retina changed thickness, and there were more deaths of retinal ganglion cells via apoptosis. This suggests that the retinal changes can be used as biomarkers for Parkinson’s disease.
 

 Even though Parkinson’s is the second most common neurodegenerative disease worldwide, diagnosis of this condition is still done largely by a process of elimination. Truly definite diagnosis of Parkinson’s is only available with histological confirmation post-mortem. Thus, this new retinal scan could be a revolutionary leap into how doctor diagnose Parkinson’s.
 
"These tests mean we might be able to intervene much earlier and more effectively treat people with this devastating condition," said Cordeiro.
 
The retina is located at the back of the eye, and can be easily screened by optometrists through non-invasive means. "Although the research is in its infancy and is yet to be tested on people with Parkinson's, a simple non-invasive test - such as an eye test - could be a significant step forward in the search for treatments that can tackle the underlying causes of the condition rather than masking its symptoms," said Arthur Roach, director of research at the charity Parkinson's UK.
 
Additional sources: BBC News, MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
OCT 28, 2020
Cancer
Protecting the Head and Neck from Off Target Radiation
OCT 28, 2020
Protecting the Head and Neck from Off Target Radiation
Radiotherapy alone or with chemotherapy is the go-to treatment for head and neck cancers. Unfortunately, head and neck t ...
NOV 06, 2020
Clinical & Molecular DX
Your Earwax Says You're Depressed
NOV 06, 2020
Your Earwax Says You're Depressed
Cortisol, commonly known as the “stress hormone”, is the body’s built-in alarm system that sends siren ...
DEC 15, 2020
Clinical & Molecular DX
Who Should Get the COVID Vaccine First?
DEC 15, 2020
Who Should Get the COVID Vaccine First?
Drug developers’ frantic hunt for vaccines against SARS-CoV-2 has finally begun to bear fruit, with several vaccin ...
DEC 26, 2020
Clinical & Molecular DX
Navigating the Genomic Landscape of Cancer in Asians
DEC 26, 2020
Navigating the Genomic Landscape of Cancer in Asians
Precision medicine — a clinical paradigm that tailors treatments specifically to patients based on their genetic a ...
JAN 22, 2021
Clinical & Molecular DX
Breast Cancer's Nasty Nine Revealed
JAN 22, 2021
Breast Cancer's Nasty Nine Revealed
Calculating an individual’s risk of developing breast cancer isn’t easy. There’s a complex interplay b ...
FEB 03, 2021
Clinical & Molecular DX
New Panel of Arthritis Biomarkers Diagnoses Disease With 93.2% Accuracy
FEB 03, 2021
New Panel of Arthritis Biomarkers Diagnoses Disease With 93.2% Accuracy
Rheumatoid arthritis, or RA, is a painful and debilitating autoimmune disorder of the joints, particularly those of the ...
Loading Comments...